AXA SA vs Morgan Stanley: Strategic Comparison

This in-depth comparison examines AXA SA and Morgan Stanley across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching AXA SA on its own, evaluating Morgan Stanley, or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between AXA SA and Morgan Stanley is widest.

On the headline numbers, AXA SA reports annual revenue of ~$131.1B against $70.6B for Morgan Stanley, while their respective market capitalizations stand at $90.3B and $330.9B. AXA SA is headquartered in France and Morgan Stanley in United States, and those different home markets shape how each company competes.

AXA SA: AXA SA is a Paris-based insurance group and one of the largest insurers in the world by revenue. It says it employs 156,000 people serving more than 92 million clients in 52 countries, and reported gross written premiums and other revenues of ~$131 billion (EUR 116 billion) for 2025. The group writes motor, home, commercial property, liability and specialty cover, life and savings contracts and health insurance, and manages the reserves backing those policies. Property and casualty is the largest business at ~$65.5 billion (EUR 58 billion) of 2025 premiums, ahead of life at ~$42.4 billion (EUR 37.5 billion) and health at ~$21.5 billion (EUR 19 billion).

Morgan Stanley: Morgan Stanley is a global investment bank and wealth manager headquartered at 1585 Broadway in New York. It is listed on the NYSE as MS, employed about 83,000 people in 42 countries at the end of 2025, and is led by Chairman and CEO Ted Pick. Its business spans Institutional Securities, Wealth Management, and Investment Management.

AXA SA and Morgan Stanley pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between AXA SA and Morgan Stanley.

AXA SA business model: AXA collects premiums across three businesses: property and casualty (motor, home, commercial property, liability and specialty risks written through AXA XL), life and savings (protection, general account savings and unit-linked contracts), and health (individual cover and employee benefits). In 2025 property and casualty premiums reached ~$65.5 billion (EUR 58 billion) and life and health premiums ~$63.8 billion (EUR 56.5 billion). Policies are sold through tied agents, brokers, bancassurance partners and direct digital channels. The group also earns investment income on the reserves it holds before claims are paid. Since selling AXA Investment Managers to BNP Paribas Cardif on July 1, 2025, AXA no longer runs a third-party asset manager and has BNP Paribas manage a large part of its own assets under a long-term agreement.

Morgan Stanley business model: Morgan Stanley reports three segments. Institutional Securities earns advisory and underwriting fees, equity and fixed-income trading revenue, prime brokerage financing, and corporate lending income. Wealth Management earns asset-based advisory fees, brokerage commissions, and net interest income on client deposits and loans across its advisor network, E*TRADE, and Morgan Stanley at Work. Investment Management earns management and performance fees on public and private-market strategies, including Eaton Vance, Parametric, and Calvert.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of AXA SA stack up against those of Morgan Stanley.

AXA SA competitive advantage: AXA's main advantage is a diversified risk pool. Writing motor, home, commercial property, liability, health and life cover in 52 countries lets one bad year in a single market or line be absorbed elsewhere: in 2025 growth in health and European commercial lines offset pressure in other portfolios. Its balance sheet supports that spread, with a Solvency II ratio of 224% at the end of 2025. The 2018 purchase of XL Group added Lloyd's market access and large-corporate broker relationships that regional insurers cannot match, and the AXA brand supports distribution through tied agents, brokers and bancassurance partners across Europe and Asia.

Morgan Stanley competitive advantage: Morgan Stanley's edge is the combination of a leading equities and advisory franchise with one of the largest wealth platforms in the US. Workplace stock plans and E*TRADE bring in employees and self-directed investors early, and advisor-led wealth management retains them as their assets grow. That mix of fee-based wealth revenue and cyclical Wall Street revenue gives it steadier earnings than a pure investment bank.

Future prospects matter as much as current results. The growth strategies below explain how AXA SA and Morgan Stanley each plan to expand from here.

AXA SA growth strategy: AXA grows mostly organically in insurance lines it can price, supplemented by bolt-on deals: Laya Healthcare in Ireland and GACM España in 2023, and a 51% stake in the Italian direct insurer Prima announced in 2025 for ~$565 million (EUR 500 million). The bigger strategic move has been simplification. AXA listed and sold down its United States life business as Equitable Holdings from 2018, bought XL Group to build commercial lines, and completed the sale of AXA Investment Managers to BNP Paribas Cardif on July 1, 2025, using part of the proceeds for a ~$4.29 billion (EUR 3.8 billion) buyback. Management also reports efficiency gains from automation and artificial intelligence in claims and service work.

Morgan Stanley growth strategy: The strategy is to grow client assets across the wealth and investment management franchise, use Morgan Stanley at Work and E*TRADE as feeders into advisor-led accounts, and keep share in equities, advisory, and underwriting. The firm also deploys AI tools for advisors, including assistants built with OpenAI.

A closer look at the financial trajectory of AXA SA and Morgan Stanley rounds out the comparison.

AXA SA: AXA's results combine large, slow-moving premium income with investment income on the reserves it holds. In 2025 gross written premiums and other revenues rose 6% to ~$131 billion (EUR 116 billion), underlying earnings rose 6% to ~$9.49 billion (EUR 8.4 billion), underlying earnings per share rose 8% to EUR 3.86 and net income rose to ~$11.1 billion (EUR 9.80 billion), helped by the gain on the sale of AXA Investment Managers. The property and casualty combined ratio improved 0.3 points to 90.6%, so underwriting itself was profitable before investment income. The Solvency II ratio ended 2025 at 224%, and 215% on January 1, 2026 once capital instruments under Solvency II transitional measures stopped qualifying. AXA proposed a dividend of EUR 2.32 per share for 2025, up 8%, alongside an annual buyback of up to $1.41 billion (EUR 1.25 billion).

Morgan Stanley: Net revenues rose from $34.6B in 2016 to $70.6B in 2025, with net income reaching $16.9B in 2025. Under James Gorman (CEO 2010-2023) the firm added Smith Barney, E*TRADE, and Eaton Vance to build recurring fee revenue. Under Ted Pick, results accelerated: Q2 2026 net revenue of $21.35B was up 27% year over year, net income of $5.58B was up 58%, and first-half 2026 revenue was about $42B with ROTCE near 27%.